Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Waseem Qasim

Showing results (1-10 of 115) with videos related to

Pageof 12
Sort By:
American Journal of Hematology|January 12, 2019
Allogeneic CAR T cell therapies for leukemiaWaseem Qasim
Blood|October 12, 2022
Genome-edited allogeneic donor "universal" chimeric antigen receptor T cellsWaseem Qasim
Emerging Topics in Life Sciences|February 1, 2021
Emerging therapeutic applications of CRISPR genome editingWaseem Qasim
Gene and Genome Editing|January 3, 2022
Genome editing of therapeutic T cellsWaseem Qasim
Expert Review of Hematology|July 5, 2017
Emerging applications of gene edited T cells for the treatment of leukemiaChristos Georgiadis, Waseem Qasim
Hematology/Oncology Clinics of North America|June 30, 2022
Genome-Edited T Cell TherapiesGiorgio Ottaviano, Waseem Qasim
Leukemia|April 8, 2025
Current landscape of vector safety and genotoxicity after hematopoietic stem or immune cell gene therapyGiorgio Ottaviano, Waseem Qasim
British Journal of Haematology|June 18, 2014
Progress and prospects for engineered T cell therapiesWaseem Qasim, Adrian J Thrasher
Expert Reviews in Molecular Medicine|November 5, 2015
Engineered T cell therapiesAnne-Christine Field, Waseem Qasim
Drugs|May 23, 2014
Gene therapy for primary immunodeficiencies: current status and future prospectsWaseem Qasim, Andrew R Gennery
Pageof 12

Showing results (1-10 of 115) with videos related to

Sort By:
Pageof 12
American Journal of Hematology|January 12, 2019
Allogeneic CAR T cell therapies for leukemiaWaseem Qasim
Blood|October 12, 2022
Genome-edited allogeneic donor "universal" chimeric antigen receptor T cellsWaseem Qasim
Emerging Topics in Life Sciences|February 1, 2021
Emerging therapeutic applications of CRISPR genome editingWaseem Qasim
Gene and Genome Editing|January 3, 2022
Genome editing of therapeutic T cellsWaseem Qasim
Expert Review of Hematology|July 5, 2017
Emerging applications of gene edited T cells for the treatment of leukemiaChristos Georgiadis, Waseem Qasim
Hematology/Oncology Clinics of North America|June 30, 2022
Genome-Edited T Cell TherapiesGiorgio Ottaviano, Waseem Qasim
Leukemia|April 8, 2025
Current landscape of vector safety and genotoxicity after hematopoietic stem or immune cell gene therapyGiorgio Ottaviano, Waseem Qasim
British Journal of Haematology|June 18, 2014
Progress and prospects for engineered T cell therapiesWaseem Qasim, Adrian J Thrasher
Expert Reviews in Molecular Medicine|November 5, 2015
Engineered T cell therapiesAnne-Christine Field, Waseem Qasim
Drugs|May 23, 2014
Gene therapy for primary immunodeficiencies: current status and future prospectsWaseem Qasim, Andrew R Gennery
Pageof 12